Literature DB >> 2459606

Epidermal growth factor activates phosphoinositide turnover and protein kinase C in BALB/MK keratinocytes.

J Moscat1, C J Molloy, T P Fleming, S A Aaronson.   

Abstract

BALB/MK is a nontransformed epithelial cell line derived from primary BALB/c mouse keratinocytes that requires epidermal growth factor (EGF) for growth. Using a defined-medium culture system, we investigated the role of physiological concentrations of EGF on phosphoinositide metabolism in these cells. The results show that EGF rapidly activates phospholipase-C mediated phosphoinositide metabolism resulting in the generation of the second messengers inositol 1,4,5-trisphosphate and diacylglycerol. These metabolites control intracellular Ca2+ levels and activate protein kinase C, respectively. Protein kinase C activation in response to EGF was evidenced by the phosphorylation of the acidic 80 kilodalton endogenous protein substrate (p80) specific for this kinase. In contrast, insulin, which acts in concert with EGF to cause BALB/MK cell proliferation, had no effect on phosphoinositide metabolism nor led to any additional stimulation when added in combination with EGF. Taken together, our results show that rapid alterations in phosphoinositide metabolism and protein kinase C activation are associated with the normal mitogenic response of keratinocytes to EGF.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2459606     DOI: 10.1210/mend-2-9-799

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  8 in total

1.  Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of proto-oncogenes c-fos and c-jun and activation of protein kinase C.

Authors:  S E McDonnell; L D Kerr; L M Matrisian
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

2.  Transcription factor PEA3 participates in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol-ester.

Authors:  P Rørth; C Nerlov; F Blasi; M Johnsen
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

3.  Epidermal growth factor stimulates tyrosine phosphorylation of phospholipase C-II independently of receptor internalization and extracellular calcium.

Authors:  M I Wahl; S Nishibe; P G Suh; S G Rhee; G Carpenter
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

4.  EGF induces ornithine decarboxylase transcription in Balb/MK keratinocytes: a proposed mechanism for the TGF alpha autocrine loop.

Authors:  P D Mier; C A van Hooijdonk; R F Freund; G J de Jongh; P E van Erp; P C van de Kerkhof
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

Review 5.  Adjuvant dietary fat intake reduction in postmenopausal breast cancer patient management. The Women's Intervention Nutrition Study (WINS).

Authors:  R T Chlebowski; D Rose; I M Buzzard; G L Blackburn; W Insull; M Grosvenor; R Elashoff; E L Wynder
Journal:  Breast Cancer Res Treat       Date:  1992-01       Impact factor: 4.872

6.  Epidermal growth factor and transforming growth factor alpha specifically induce the activation- and hyperproliferation-associated keratins 6 and 16.

Authors:  C K Jiang; T Magnaldo; M Ohtsuki; I M Freedberg; F Bernerd; M Blumenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

7.  Inositol phosphate formation and release of intracellular free calcium by bradykinin in HaCaT keratinocytes.

Authors:  T Rosenbach; C Liesegang; S Binting; B M Czarnetzki
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

8.  Differential induction of phosphatidylcholine hydrolysis, diacylglycerol formation and protein kinase C activation by epidermal growth factor and transforming growth factor-alpha in normal human skin fibroblasts and keratinocytes.

Authors:  N J Reynolds; H S Talwar; J J Baldassare; P A Henderson; J T Elder; J J Voorhees; G J Fisher
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.